WHITEHAWK THERAPEUTICS, INC. Interest Expense, Related Party
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Interest Expense, Related Party of $600.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-17.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseRelatedParty · last filed 2022-03-17
- WHITEHAWK THERAPEUTICS, INC. interest expense, related party for the quarter ending 2021-12-31 was $58.00K, a 71.43% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. interest expense, related party for the quarter ending 2021-09-30 was $142.00K, a 30.39% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. interest expense, related party for the quarter ending 2020-12-31 was $203.00K.
- WHITEHAWK THERAPEUTICS, INC. interest expense, related party for the quarter ending 2020-09-30 was $204.00K.
- WHITEHAWK THERAPEUTICS, INC. interest expense, related party for fiscal 2021 was $600.00K, a 18.26% decline from fiscal 2020.
- WHITEHAWK THERAPEUTICS, INC. interest expense, related party for fiscal 2020 was $734.00K.
| Period end | Interest Expense, Related Party 3 month | Interest Expense, Related Party 6 month | Interest Expense, Related Party 9 month | Interest Expense, Related Party 12 month |
|---|---|---|---|---|
| 2021-12-31 | $58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $200.00K derived: sum of 2 quarters · filed 2022-03-17 | $600.00K 10-K · filed 2022-03-17 | |
| 2021-09-30 | $142.00K 10-Q · filed 2021-11-10 | $542.00K 10-Q · filed 2021-11-10 | ||
| 2020-12-31 | $203.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $407.00K derived: sum of 2 quarters · filed 2022-03-17 | $734.00K 10-K · filed 2022-03-17 | |
| 2020-09-30 | $204.00K 10-Q · filed 2021-11-10 | $531.00K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |